Child Thriving After Becoming World's Youngest to Receive Gene Therapy for AADC Deficiency
Sriansh Ojha was fully into his "terrible twos" on an April afternoon at Cincinnati Children's as he squealed and chased his ...
Poseida Therapeutics: Promising Advancements and Strategic Collaborations Drive Buy Rating
William Blair analyst Sami Corwin has maintained their bullish stance on PSTX stock, giving a Buy rating on November 8. Sami Corwin has given ...
Daily8h
FDA Approves First Gene Therapy for Treatment of AADC deficiency
The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus ...
MM&M10h
Rx Rundown: Roche, Metsera, Intercept Pharmaceuticals and more
AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
Pharmabiz18h
PTC Therapeutics’ gene therapy, Kebilidi to treat AADC deficiency receives US FDA approval
PTC Therapeutics’ gene therapy, Kebilidi to treat AADC deficiency receives US FDA approval: Warren, New Jersey Friday, November 15, 2024, 10:00 Hrs [IST] PTC Therapeutics, Inc., ...
Otago’s golden future: Santana’s PFS forecasts $1bn NPV
Santana Minerals (ASX:SMI) has released its Pre-Feasibility Study (PFS) results for the Bendigo-Ophir Gold Project in New ...